Cardinal Health (CAH) fundamentals: P/E, valuation, undervalued?
Cardinal Health · Health Care · ref. ETF XLV · price $239.72
In short — Cardinal Health trades at 33.2× earnings (P/E), 17.1× forward, with a net margin of 0.7 % and revenue growth of +6 %. Read: Cheap for the growth (P/E 17 for ~69% growth (PEG 0.2)).
Is Cardinal Health stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$239.72+55.5% over range
Oct 14, 25low $153.27 · high $248.61Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
92% recommend buying · 13 analysts
Valuation : Cheap for the growth — P/E 17 for ~69% growth (PEG 0.2)
Valuation
33.2
P/E (price/earnings)
17.1
Forward P/E
0.48
PEG
—
Price/book (P/B)
$55.5B
Market cap
7.21
EPS
Profitability & growth
0.7 %
Net margin
+6 %
Revenue growth
+69 %
Earnings growth
$10.0B
Total debt
Cardinal Health income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2023 | $205.0B | $261M | 0.1 % |
| 2024 | $226.8B | $852M | 0.4 % |
| 2025 | $222.6B | $1.6B | 0.7 % |
| 2026 | $254.2B | $1.7B | 0.7 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Cardinal Health's P/E and is the stock undervalued? What's a good P/E?
Cardinal Health's P/E is 33.2 (forward 17.1). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is Cardinal Health profitable?
Cardinal Health has a net margin of 0.7 % (EPS 7.21). The company is profitable.
Is CAH stock expensive?
Our read: "Cheap for the growth" — P/E 17 for ~69% growth (PEG 0.2). Cross-check with growth and sector.
💬 A question about Cardinal Health? The JPI assistant answers using our backtest data.
Keep exploring Cardinal Health